These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 10406680)

  • 21. Sterile inflammation after transradial catheterization using a hydrophilic sheath: a case report.
    Ziakas A; Karkavelas G; Mochlas S
    Int J Cardiol; 2005 Mar; 99(3):495-6. PubMed ID: 15771941
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful treatment of coronary artery perforation during angioplasty using a new membrane-coated stent.
    Casella G; Werner F; Klauss V; Mudra H
    J Invasive Cardiol; 1999 Oct; 11(10):622-6. PubMed ID: 10745446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The conversion in application of percutaneous coronary intervention following the introduction of drug eluting stents.
    Ikeno F; Raissi Shabari F; Sadoughi A; Lyons JK; Pourdehmobed K; Hashemi V; Emami S; Kaneda H; Yeung AC; Rezaee M
    Int J Cardiol; 2006 Nov; 113(2):279-80. PubMed ID: 16318883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-inflammatory stent coatings: dexamethasone and related compounds.
    Park SH; Lincoff AM
    Semin Interv Cardiol; 1998; 3(3-4):191-5. PubMed ID: 10406692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomimicry 1: PC.
    Cumberland DC; Gunn J; Malik N; Holt CM
    Semin Interv Cardiol; 1998; 3(3-4):149-50. PubMed ID: 10406685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries.
    Johnson TW; Wu YX; Herdeg C; Baumbach A; Newby AC; Karsch KR; Oberhoff M
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):754-9. PubMed ID: 15681295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of heparin coating of coronary stents and ex vivo efficacy of different doses of acetylsalicylic acid and ticlopidine in a pulsed floating model of recirculating human plasma.
    Brockmann MA; Gutensohn K; Bau J; Kuehnl P; Meinertz T; Nienaber C; Beythien C
    Platelets; 2002 Dec; 13(8):443-9. PubMed ID: 12487777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
    Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
    J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stent-based percutaneous coronary interventions in small coronary arteries.
    Roguin A; Grenadier E
    Acute Card Care; 2006; 8(2):70-4. PubMed ID: 16885069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
    Bhargava B; Reddy NK; Karthikeyan G; Raju R; Mishra S; Singh S; Waksman R; Virmani R; Somaraju B
    Catheter Cardiovasc Interv; 2006 May; 67(5):698-702. PubMed ID: 16575925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ongoing foreign body reaction to subcutaneous implanted (heparin) modified Dacron in rats.
    van Bilsen PH; Popa ER; Brouwer LA; Vincent J; Taylor CE; de Leij LF; Hendriks M; van Luyn MJ
    J Biomed Mater Res A; 2004 Mar; 68(3):423-7. PubMed ID: 14762921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nude stents, coated stents].
    Puel J
    Bull Acad Natl Med; 2005 Feb; 189(2):237-47. PubMed ID: 16114855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Closure of an iatrogenic coronary artery fistula with a PTFE-coated stent].
    Mestre Barceló JL; Salido Tahoces L; del Río del Busto A; Camino López A; Moya Mur JL; Pey Illera J
    Rev Esp Cardiol; 2004 Jul; 57(7):699-701. PubMed ID: 15274856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complex coronary intervention in the drug-eluting stent era. Introduction.
    Kereiakes DJ
    Rev Cardiovasc Med; 2005; 6 Suppl 1():S1-2. PubMed ID: 15665792
    [No Abstract]   [Full Text] [Related]  

  • 35. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
    Ma GS; Chen LJ; Chen Z; Ding S; Shen CX; Feng Y
    Biomed Pharmacother; 2008 Feb; 62(2):125-9. PubMed ID: 17764890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating.
    Wessely R; Hausleiter J; Michaelis C; Jaschke B; Vogeser M; Milz S; Behnisch B; Schratzenstaller T; Renke-Gluszko M; Stöver M; Wintermantel E; Kastrati A; Schömig A
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):748-53. PubMed ID: 15681298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.
    Jabara R; Chronos N; Robinson K
    Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Covered stents: a review.
    Jamshidi P; Mahmoody K; Erne P
    Int J Cardiol; 2008 Nov; 130(3):310-8. PubMed ID: 18672301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sirolimus- and taxol-eluting stents differ towards intimal hyperplasia and re-endothelialization.
    Liuzzo JP; Ambrose JA; Coppola JT
    J Invasive Cardiol; 2005 Sep; 17(9):497-502. PubMed ID: 16145242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo.
    Lewis AL; Willis SL; Small SA; Hunt SR; O'byrne V; Stratford PW
    Biomed Mater Eng; 2004; 14(4):355-70. PubMed ID: 15472385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.